News About: Pharm. Industry
Total health food supplement market volume estimated at 1.1
The health food supplement products showed a remarkable market growing trend these days, estimating the total market volume at 1.1 trillion won this year, said the Korea Health Supplement and Special Diet Food Associa...
Anti-hypertensive drug market predominated by 5 leading foreign multinational corporations.
A market survey conducted by Medical Space Co. (www.medicalspace.co.kr) from Aug. to Nov. last year reported that 5 leading foreign multinational drug corporations including MSD, Bayer, Handok, Sanofi-Sythelab...
SNA college of pharmacy venture to tie up with Cheiljedang
Gingseng Science (Representative; Park Jung-il), a venture company affiliated to Seoul National Univ. College of Pharmacy set up a business tie-up with Cheil Jedang (President: Sohn Kyong-shik) on Feb. 1, allowing 10%...
Drug overseas export sales very slow last year.
The pharmaceutical export last year showed very slow while the import rose remarkably, indicating unbalanced international trades in pharmaceutical industrial sector.
According to the KPhTA report dated on Feb. 8 a...
Insurance drug price to adjust only when price dumping trade identified.
The price reduction of medical insurance drugs will be made only for the item, through the hearing process, identified with evidence of its price dumping, which may remarkably relieve the industrial discomfort along w...
Upper price limits set up for 745 new insurance drugs.
The upper price limits for 745 new insurance drugs have been determined at
the Drug Expert Committee's meeting to take effect from February 10.
The new drugs by therapeutic category showed 1) 84 items (64 oral, 11 ...
Stock prices of drug industry plunged by total 270.2 billion won as of year end.
The total stock value of the listed pharmaceutical companies revealed 270,200 million won of losses in 2000 according to the stock exchange statistics reported on Dec. 22, 2000 against major 36 stock listed drug compa...
All medical and pharmaceutical professions in struggle to gain their own shares.
Irrespective of the external environmental changes in the medical and pharmaceutical professions as resulted from implementation of the government's medical and pharmacy role separation system and of the new medical...
Anti-arthritis drug, Milican inj. on clinical phase IIb.
Dongwha Pharmaceutical company announced that Milican inj. a new anti-rheumatoid arthritis agent, completed its clinical phase I and IIa studies, and the phase IIb study seemed to follow soon according to the KFDA's a...
Foreign multinational drug corporations predominated whole anti-cancer markets
According to a survey conducted by Medicalspace Co., a cyber medical information
company from Aug. to Nov. last year over 20 leading general hospitals (800 beds
on average) (President: Mr. LeeByung-wook, www.m...
